Update shared on 13 Dec 2025
Fair value Increased 0.36%Analysts have raised their fair value estimate for CME Group by about $1 to roughly $286 per share, citing the company’s resilient clearing and transaction fee driven revenue base, modestly higher long term growth expectations, and a reinforced competitive moat highlighted in recent target revisions across the Street.
Analyst Commentary
Street research on CME Group reflects a wide range of views on valuation and execution, with recent target changes clustering around expectations for resilient fee income but diverging on the sustainability of growth and the impact of lower volatility.
Bullish Takeaways
- Bullish analysts highlight CME Group's high proportion of revenues from clearing and transaction fees as a key driver of durable, relatively low beta earnings. This is cited as supporting premium valuation multiples.
- The breadth and depth of CME's futures and options complex are viewed as reinforcing a strong competitive moat. This is seen as positioning the company as a primary beneficiary of ongoing macro and credit uncertainty.
- Recent upward price target revisions, including moves into the low to mid $300 range, are interpreted as signaling growing confidence in modestly higher long term growth expectations and continued operating leverage.
- Ongoing innovation around prediction and derivatives related products, including partnerships and adjacent offerings, is seen as a potential incremental growth vector that can extend CME's addressable market over time.
Bearish Takeaways
- Bearish analysts emphasize the sensitivity of volumes to volatility, noting that significantly lower volatility in the recent quarter has pressured trading activity across several asset classes and weighed on near term earnings power.
- Some target cuts into the low $200s underscore concerns that the current valuation embeds optimistic assumptions on sustained volume strength that may prove difficult to meet in a normalized volatility regime.
- Equal Weight and Underweight stances, including from JPMorgan with a target in the mid $200s, reflect caution on upside potential given slower energy trading activity and a more muted outlook for short term catalysts.
- There is also a view that, while CME's moat is strong, growth may decelerate from recent elevated levels. This could limit multiple expansion and leave the shares more vulnerable if macro conditions stabilize and hedging demand recedes.
What's in the News
- CME Group received SEC approval to register CME Securities Clearing Inc, a new securities clearing house designed to support compliance with upcoming U.S. Treasury and repo clearing mandates, with launch targeted for the second quarter of 2026 (company announcement).
- The company and FanDuel unveiled the FanDuel Predicts app, a standalone U.S. platform for trading event contracts tied to major sports, equity indices, commodities, cryptocurrencies, and key economic indicators, expanding CME's reach into retail oriented prediction markets (company announcement).
- CME Group announced plans to launch two non tradable bitcoin volatility indices, BVX and BVXS. These will provide real time and settlement measures of 30 day implied bitcoin volatility derived from activity in its regulated bitcoin options complex (company announcement).
- The firm opened a new office in Dubai's DIFC under a DFSA license. This marks a formal expansion into the Middle East and supports regional FX and derivatives demand, including the listing of the USD/AED currency pair on EBS platforms (company announcement).
- CME Group intends to debut financial contracts tied to sports games and economic indicators by year end. This positions the firm to compete more directly with prediction market platforms such as Kalshi and Polymarket (Bloomberg).
Valuation Changes
- The fair value estimate has risen slightly, increasing from approximately $285.12 per share to about $286.13 per share.
- The discount rate has edged higher, moving from roughly 8.18 percent to about 8.20 percent, implying a marginally higher required return.
- The revenue growth assumption has risen slightly, from around 4.52 percent to approximately 4.54 percent annually.
- The net profit margin expectation has nudged down fractionally, slipping from about 54.80 percent to roughly 54.77 percent.
- The future P/E multiple has increased modestly, from about 32.61x forward earnings to approximately 32.75x.
Have other thoughts on CME Group?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.
